Small molecule imaging: Dyeing for diabetes
Discovery of the first small fluorescent probe for a pancreatic hormone could shed light on pancreatic diseases
Using a small boron-based molecule, glucagon—a hormone that plays a key role in pancreatic diseases—can now be imaged in live pancreatic cells. This breakthrough discovery was made by a team led by Young-Tae Chang from the Singapore Bioimaging Consortium of A*STAR.
Produced in alpha cells of the pancreas, glucagon is a hormone peptide that, in partnership with insulin, maintains glucose levels in the blood. Glucagon production increases when the concentration of blood glucose decreases; an imbalance between insulin and glucagon results in diabetic disease.
Glucagon secretion has been studied extensively, but progress has been hampered by a lack of suitable probes for imaging the hormone in real time inside live cells and tissues. The current method, using antibodies, can only be used to take a snap shot of a dead cell. “Our glucagon probe can be used for imaging live cells, over a long period of time,” says Chang.
In their alternative approach, the team first made a library of small molecules consisting of a molecular component (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene, or BODIPY), which fluoresces when the molecule binds to glucagon directly attached to different chemical entities. The team selected 1,3-dimethyl-BODIPY as their fluorescent scaffold and reacted it with 238 different aromatic aldehydes in a microwave. This produced 160 compounds that were pure enough to be screened against live cells. This is the first report of a systematic construction of a library based on BODIPY, notes Chang.
The researchers assessed the compounds using an in vitro high-throughput screen against three different live cell lines—pancreatic alpha cells, pancreatic beta cells (which produce insulin), and control HeLa cells. From fluorescent images taken at different time intervals, they found that one of the compounds exhibited a selective and highly fluorescent response to the glucagon-secreting alpha cell line. They named this compound glucagon yellow, owing to its yellow fluorescence signal and selective fluorescence increase upon binding to glucagon (Fig. 1).
“Next we would like to find more alpha cell dyes, and also beta cell selective dyes,” Chang says. Through collaborations with positron emission tomography (PET) and single photon emission computed tomography (SPECT) experts at the Singapore Bioimaging Consortium, Chang also plans to try imaging the pancreas in situ using his team’s compounds. “The fluorescent molecule itself may not be a robust imaging probe in clinical applications,” but through team work he says “our dye will be converted in PET/SPECT probes, and will be applied to animal and clinical usage.”
The A*STAR affiliated authors in this highlight are from the Singapore Bioimaging Consortium
Source: A Star Research /...
The Institute of Nanotechnology puts significant effort into ensuring that the information provided on its news pages is accurate and up-to-date. However, we cannot guarantee absolute accuracy. Consequently, the Institute of Nanotechnology disclaims any and all responsibility for inaccuracy, omission or any kind of deficiency in relation to the news items and articles hosted herein.
- 03 September 2014New Synthesis Method May Shape Future of Nanostructures, Clean Energy
- 14 August 2014“Trojan horse” treatment could beat brain tumours
- 13 August 2014Copper foam turns CO2 into useful chemicals
- 29 July 2014Nanotechnology and tyres: Greening industry and transport
- 22 July 2014Supporting Recommendations for Future Topics in Horizon 2020
- View All